BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 11606073)

  • 1. Hepatocyte growth factor/scatter factor is implicated in the mode of stromal invasion of uterine squamous cervical cancer.
    Shimabukuro K; Ichinose S; Koike R; Kubota T; Yamaguchi M; Miyasaka M; Aso T
    Gynecol Oncol; 2001 Nov; 83(2):205-15. PubMed ID: 11606073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.
    Kim CH; Kim J; Kahng H; Choi EC
    Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+).
    Weimar IS; Miranda N; Muller EJ; Hekman A; Kerst JM; de Gast GC; Gerritsen WR
    Exp Hematol; 1998 Aug; 26(9):885-94. PubMed ID: 9694510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion.
    Davies G; Jiang WG; Mason MD
    Clin Cancer Res; 2001 Oct; 7(10):3289-97. PubMed ID: 11595727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor promotes in vitro scattering and morphogenesis of human cervical carcinoma cells.
    Wong AS; Leung PC; Auersperg N
    Gynecol Oncol; 2000 Aug; 78(2):158-65. PubMed ID: 10926796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice.
    Weimar IS; Weijer K; van den Berk PC; Muller EJ; Miranda N; Bakker AQ; Heemskerk MH; Hekman A; de Gast GC; Gerritsen WR
    Br J Cancer; 1999 Sep; 81(1):43-53. PubMed ID: 10487611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of E-cadherin by hepatocyte growth factor and effect on the prognosis of nasopharyngeal carcinoma.
    Xie LQ; Bian LJ; Li Z; Li Y; Li ZX; Li B
    Ann Surg Oncol; 2010 Jul; 17(7):1927-36. PubMed ID: 20131016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of junction assembly in cultured epithelial cells by hepatocyte growth factor/scatter factor is concomitant with increased stability and altered phosphorylation of the soluble junctional molecules.
    Pasdar M; Li Z; Marreli M; Nguyen BT; Park M; Wong K
    Cell Growth Differ; 1997 Apr; 8(4):451-62. PubMed ID: 9101091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
    Kataoka H; Hamasuna R; Itoh H; Kitamura N; Koono M
    Cancer Res; 2000 Nov; 60(21):6148-59. PubMed ID: 11085539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hepatocyte growth factor (HGF)/scatter factor (SF) on cell adhesion in gastric cancer.
    Tannapfel A; Wittekind C; Tahara E
    Z Gastroenterol; 1994 Feb; 32(2):91-3. PubMed ID: 8165832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte growth factor (HGF) induces invasion of endometrial carcinoma cell lines in vitro.
    Bae-Jump V; Segreti EM; Vandermolen D; Kauma S
    Gynecol Oncol; 1999 May; 73(2):265-72. PubMed ID: 10329045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of HGF/SF-Met signaling in prostate adenocarcinoma cells: evidence for alternative mechanisms leading to a metastatic phenotype in Pr-14c.
    MacDougall CA; Vargas M; Soares CR; Holzer RG; Ide AE; Jorcyk CL
    Prostate; 2005 Jul; 64(2):139-48. PubMed ID: 15678502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion.
    Murai M; Shen X; Huang L; Carpenter WM; Lin CS; Silverman S; Regezi J; Kramer RH
    Int J Oncol; 2004 Oct; 25(4):831-40. PubMed ID: 15375530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the HGF/SF receptor c-met using a hammerhead ribozyme transgene reduces in vitro invasion and migration in prostate cancer cells.
    Davies G; Watkins G; Mason MD; Jiang WG
    Prostate; 2004 Sep; 60(4):317-24. PubMed ID: 15264243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of endothelial CD44 expression and endothelium-tumour cell interactions by hepatocyte growth factor/scatter factor.
    Hiscox S; Jiang WG
    Biochem Biophys Res Commun; 1997 Apr; 233(1):1-5. PubMed ID: 9144384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complex formation of IQGAP1 with E-cadherin/catenin during cohort migration of carcinoma cells. Its possible association with localized release from cell-cell adhesion.
    Shimao Y; Nabeshima K; Inoue T; Koono M
    Virchows Arch; 2002 Aug; 441(2):124-32. PubMed ID: 12189501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-cell adhesion molecules and their associated proteins in bladder cancer cells and their role in mitogen induced cell-cell dissociation and invasion.
    Davies G; Jiang WG; Mason MD
    Anticancer Res; 1999; 19(1A):547-52. PubMed ID: 10226596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E-cadherin increases squamous cell carcinoma antigen expression through phosphatidylinositol-3 kinase-Akt pathway in squamous cell carcinoma cell lines.
    Nakagawa T; Murakami A; Torii M; Nawata S; Takeda O; Sugino N
    Oncol Rep; 2007 Jul; 18(1):175-9. PubMed ID: 17549365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte growth factor/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases.
    Harvey P; Clark IM; Jaurand MC; Warn RM; Edwards DR
    Br J Cancer; 2000 Nov; 83(9):1147-53. PubMed ID: 11027427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions.
    Nakamura T; Matsumoto K; Kiritoshi A; Tano Y; Nakamura T
    Cancer Res; 1997 Aug; 57(15):3305-13. PubMed ID: 9242465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.